You are viewing: Mexico Endoscopic Submucosal Dissection/ESD Market analysis

The Mexico Endoscopic Submucosal Dissection/ESD Market was valued at $2.8 Million in 2025 and projected to reach to $4 Million by 2030, representing a compound annual growth rate of CAGR 7.6%. Mexico's Endoscopic Submucosal Dissection market is positioned for steady growth driven by rising healthcare expenditures and increasing awareness of minimally invasive treatment options.

Mexico Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • This growth trajectory reflects Mexico's increasing adoption of minimally invasive endoscopic procedures and rising healthcare infrastructure investments.
  • Mexico's ESD market expansion is driven by growing prevalence of gastrointestinal cancers and improved access to advanced diagnostic and therapeutic technologies across major metropolitan healthcare centers. The Mexican healthcare sector is witnessing accelerated modernization, with private and public institutions in Mexico investing in state-of-the-art endoscopic equipment and training programs.
  • Mexico's ESD market benefits from rising patient awareness, physician expertise development, and reimbursement improvements that facilitate procedure adoption.
  • Between 2025 and 2030, Mexico is expected to see increased clinical adoption of ESD as a preferred treatment modality for early-stage gastrointestinal lesions, supported by regional medical societies and healthcare policy initiatives..

Key Market Statistics

  • CAGR (2025-2030) CAGR 7.6%
  • Market Size, 2025 ~USD 2.8 Million
  • Forecast, 2030 ~USD 4 Million
  • Country Mexico

Mexico Endoscopic Submucosal Dissection/ESD Market Overview

Market Valuation :

Mexico's ESD market is valued at USD 2.8 million in 2025, with projected growth to USD 4.0 million by 2030, representing a 7.6% CAGR.

Healthcare Infrastructure Growth :

Increasing investments in Mexico's healthcare infrastructure are driving adoption of advanced minimally invasive endoscopic procedures, particularly in urban centers.

Procedural Adoption Trends :

Mexican hospitals and specialized endoscopy centers are increasingly adopting ESD techniques for early-stage gastrointestinal cancer treatment and polyp removal.

Competitive Positioning :

Mexico's ESD market growth rate of 7.6% is slightly below the global average of 8.4%, indicating emerging market potential with room for expansion.

Mexico Endoscopic Submucosal Dissection/ESD Market Dynamics

  • The country's expanding middle class and improved access to specialized medical facilities are creating favorable conditions for ESD adoption among both patients and healthcare providers.
  • Government initiatives to enhance diagnostic and therapeutic capabilities in public hospitals are expected to accelerate market penetration.
  • Additionally, training programs for gastroenterologists in advanced endoscopic techniques are strengthening the technical foundation for market expansion.
  • By 2030, Mexico's ESD market is anticipated to reach USD 4.0 million, reflecting growing demand for tissue-sparing surgical alternatives and improved patient outcomes in gastrointestinal disease management..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Mexico's ESD market is valued at USD 2.8 million in 2025 and will reach USD 4.0 million by 2030, growing at 7.6% CAGR.
    • Mexico's healthcare infrastructure modernization and rising gastrointestinal cancer prevalence are primary growth catalysts for ESD adoption.
    • Mexico's private and public healthcare institutions are increasingly investing in endoscopic training and advanced equipment capabilities.
    • Mexico's ESD market growth is supported by improved reimbursement policies and rising physician expertise in minimally invasive procedures.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    Mexico Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS0.971.021.111.191.281.381.481.597.4
    HOSPITALS3.083.273.573.824.144.474.825.217.9
    OTHER END USERS0.150.160.170.180.190.20.210.226.1
    SPECIALTY CLINICS1.061.111.211.291.381.481.591.77.1
    TOTAL5.265.566.066.476.997.548.18.737.6

    Target Audience

    • Medical Device Manufacturers : ESD equipment and accessory manufacturers need Mexico-specific market data to develop localized product strategies and identify distribution partnerships.
    • Healthcare Investors : Investment firms evaluating Latin American healthcare opportunities require detailed Mexico market analysis to assess growth potential and ROI projections.
    • Hospital and Clinic Operators : Mexican healthcare facility administrators need market insights to justify ESD program investments and understand competitive positioning within their regions.
    • Gastroenterology Associations : Professional medical organizations in Mexico require market data to advocate for ESD training programs and establish clinical practice guidelines.
    • Healthcare Consultants : Management consulting firms advising healthcare clients in Mexico need comprehensive market intelligence to support strategic planning and expansion decisions.

    Key Companies in the Mexico Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Market Entry Strategy : Gain actionable insights into Mexico's ESD market dynamics to develop targeted market entry strategies and identify high-potential regions for device distribution.
    • Competitive Intelligence : Understand Mexico-specific competitive landscape, key players, and market positioning to benchmark your offerings against local and international competitors.
    • Growth Opportunity Assessment : Evaluate the 7.6% CAGR growth trajectory and USD 1.2 million market expansion opportunity to prioritize Mexico within your regional investment portfolio.
    • Healthcare Provider Insights : Access data on hospital adoption rates, endoscopy center capabilities, and physician preferences to tailor sales and marketing approaches for Mexican healthcare institutions.
    • Regulatory and Reimbursement Landscape : Understand Mexico's healthcare reimbursement environment, regulatory requirements, and pricing dynamics specific to ESD procedures and equipment.

    Frequently asked questions

    What is the current market size of ESD in Mexico?

    Mexico's ESD market is valued at USD 2.8 million in 2025 and is expected to grow to USD 4.0 million by 2030.

    What is the projected growth rate for Mexico's ESD market?

    Mexico's ESD market is projected to grow at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2030.

    What factors are driving ESD market growth in Mexico?

    Key drivers include rising gastrointestinal cancer prevalence, healthcare infrastructure modernization, increased physician training, and improved reimbursement policies in Mexico.

    Which healthcare institutions in Mexico are adopting ESD technology?

    Both private and public healthcare institutions across Mexico's major metropolitan areas are investing in ESD equipment and training programs.

    How does Mexico's ESD market compare to other North American countries?

    Mexico's ESD market at 7.6% CAGR reflects strong regional growth potential, though market penetration varies across North American healthcare systems based on infrastructure and reimbursement frameworks.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status